Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral Presentations - Physicians/Scientists/Pharmacists

99mTc-MIBI scintigraphy in multiple myeloma (MM): Correlation with the International Staging System (ISS)

John Koutsikos, Theodoros Athanasoulis, Vasiliki Grigoraki, Antigone Velidaki, Nikolaos Anagnostopoulos, Christos Poziopoulos, Cherry Zerva, Evagelos Georgiou and Meletios Dimopoulos
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 50P;
John Koutsikos
1Nuclear Medicine Department, 401 General Army Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theodoros Athanasoulis
2Nuclear Medicine Department, Alexandra University Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vasiliki Grigoraki
3Department of Hematology, Genimata General Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antigone Velidaki
1Nuclear Medicine Department, 401 General Army Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolaos Anagnostopoulos
3Department of Hematology, Genimata General Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christos Poziopoulos
1Nuclear Medicine Department, 401 General Army Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cherry Zerva
2Nuclear Medicine Department, Alexandra University Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evagelos Georgiou
4Medical Physics Department, University of Athens School of Medicine, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meletios Dimopoulos
5Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

146

Objectives: 99mTc-sestamibi (MIBI) scintigraphy has proved to be useful in the evaluation of MM patients. In particular, a relationship has been demonstrated between scintigraphic patterns of 99mTc-MIBI uptake and both clinical status and stage. Combinations of prognostic factors were suggested for staging classification of myeloma patients. The new ISS was developed using univariate and multivariate analyses. Serum beta2-microglobulin (Sβ2M) and serum albumin (SA) were selected from the various potential prognostic factors both because of their statistical power in various models as well as the known wide availability of these two simple inexpensive laboratory tests.The purpose of this study was to assess the correlation between the 99mTc-MIBI scan and prognostic factors in MM patients according to the ISS.

Methods: Twenty-five MM patients were studied. Eighteen mCi (660 MBq) 99mTc-MIBI were injected intravenously in each patient and the scans were obtained 10 min post injection. The scans were classified as: Normal (N) [when only normal physiological uptake was present], Diffuse (D) [when diffuse bone marrow uptake was observed], Focal (F) [when areas of local uptake of the tracer were evident], Focal and Diffuse (F+D) [when both patterns were observed]. The scans were scored according to intensity (I) and extent (E) of the radiotracer uptake; a summed score (S) was calculated for each patient. Scintigraphic findings were correlated by simple linear regression analysis with ISS, Sβ2M, and SA.

Results: Of the 25 patients, 7 patients showed only a D pattern of 99mTc-MIBI uptake. F 99mTc-MIBI uptake was the only finding in 6 patients and F+D bone marrow uptake in 5 patients. Normal physiological uptake was present in 7 patients. Eighteen pts were stage I, 3 stage II and 4 stage III. The S was 2.28±2.2 for stage I and 5±0.58 for stage II and III (p<0.001). There was a positive correlation between scores and Sβ2M and an inverse correlation between scores and SA; statistically significant differences were found between E and S scores and Sβ2M, and SA levels. Statistically significant differences were also found in scores for those patients who died as against for those alive at the end of the follow –up period.

Conclusions: 99mTc-MIBI scan provides useful information in the detection of disease activity, well correlated with Sβ2M, SA and ISS staging system.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 47, Issue suppl 1
May 1, 2006
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
99mTc-MIBI scintigraphy in multiple myeloma (MM): Correlation with the International Staging System (ISS)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
99mTc-MIBI scintigraphy in multiple myeloma (MM): Correlation with the International Staging System (ISS)
John Koutsikos, Theodoros Athanasoulis, Vasiliki Grigoraki, Antigone Velidaki, Nikolaos Anagnostopoulos, Christos Poziopoulos, Cherry Zerva, Evagelos Georgiou, Meletios Dimopoulos
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 50P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
99mTc-MIBI scintigraphy in multiple myeloma (MM): Correlation with the International Staging System (ISS)
John Koutsikos, Theodoros Athanasoulis, Vasiliki Grigoraki, Antigone Velidaki, Nikolaos Anagnostopoulos, Christos Poziopoulos, Cherry Zerva, Evagelos Georgiou, Meletios Dimopoulos
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 50P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral Presentations - Physicians/Scientists/Pharmacists

  • Early stage assessment of intrabronchial valve placement by Xe ventilation/Tc MAA perfusion scintigraphy in patients with severe emphysema
  • Diagnosis ability of dual-phase F-18-fluoro-2-deoxy-D-glucose SPECT/PET for distinguishing the benign and malignant lesions
  • Accuracy of 18F-FDG-PET/CT in the detection of malignant ovarian lesions: Correlation with ultrasound and histopathological findings
Show more Oral Presentations - Physicians/Scientists/Pharmacists

Oncology Track

  • Early stage assessment of intrabronchial valve placement by Xe ventilation/Tc MAA perfusion scintigraphy in patients with severe emphysema
  • Diagnosis ability of dual-phase F-18-fluoro-2-deoxy-D-glucose SPECT/PET for distinguishing the benign and malignant lesions
  • Accuracy of 18F-FDG-PET/CT in the detection of malignant ovarian lesions: Correlation with ultrasound and histopathological findings
Show more Oncology Track

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire